Division of Nephrology and Hypertension

January 13, 2022

The role of integrins in kidney “integrity”

Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered.

By Bill Snyder
Osama El Shamy, MD, and Megha Salani, MD, are working to expand VUMC’s Home Dialysis Program.
August 19, 2021

Home Dialysis Program experiencing rapid growth

Osama El Shamy, MD, assistant professor of Medicine in the Division of Nephrology and Hypertension, has long been a proponent of the benefits of home dialysis.

By Emily Stembridge
August 5, 2021

Gene expression in diabetic nephropathy

Vanderbilt researchers are looking to mRNA populations in podocytes — kidney cells that help filter blood — to help identify potential targets for treating diabetic kidney disease.

By Shivani Sharma
October 5, 2020

Clue to diabetic kidney disease

Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication.

By Sarah E. Glass
William Fissell, MD, has been working on the Kidney Project to create an implantable bioartificial kidney for the last decade.
July 22, 2020

VUMC, UCSF win KidneyX award for implantable home dialysis system

A $500,000 KidneyX prize has been awarded to The Kidney Project — a collaboration between Vanderbilt University Medical Center and University of California, San Francisco (UCSF) — for the development of an implantable dialysis system that would enable patients to safely and effectively treat kidney failure at home.

By Kelsey Herbers
June 4, 2020

Protecting the injured kidney

Leslie Gewin and colleagues have upended conventional dogma about Wnt/beta-catenin signaling in the kidney, finding that it protects against chronic kidney disease rather than promoting it.

By Leigh MacMillan
May 18, 2020

Implant one day may replace dialysis

Vanderbilt researchers used pharmacological manipulations to increase salt and water transport by kidney cells grown in culture, a step necessary for realizing an implantable artificial kidney device.
By Anivarya Kumar
February 18, 2020

Barbershops targeted to improve health of black men

Black men with high blood pressure could benefit from a research study beginning this month to check their vitals while they are getting a haircut at a barbershop.
By Kelsey Herbers
February 13, 2020

Nashville VA dialysis unit named in Stone’s honor

The Nashville Veterans Affairs Medical Center has dedicated its dialysis unit to William Stone, MD, a nephrologist and professor of Medicine at VUMC
By Kelsey Herbers
May 2, 2019

Wilson appointed to ASGCT board of directors

The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as an at-large director.
By Kelsey Herbers
June 28, 2018

Ikizler to succeed Harris as Nephrology and Hypertension director

Jun. 28, 2018—T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1.
By Bill Snyder
March 15, 2018

Research explores barriers to kidney disease screening

New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.
By VUMC News and Communications
September 28, 2017

Major grant to enhance kidney disease research

Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.
By Doug Campbell
1 2 3